t
| Date | 17 Apr 2023 |
| Time | 09:54:00 |
| Category | Directorate change |
| ID | nsm:202304170454PR_NEWS_UKDISCLO_0040.html |
Disseminated via PRN on 17 April 2023
PR Newswire
London, April 17
Medcaw Investments Plc
(“Medcaw Investments” or the “Company”)
Board Role Changes
Medcaw Investments Plc (LSE:MCI), a special purpose acquisition vehicle, announces that it has re-structured its internal board roles and responsibilities as follows:-
Non-Executive Director Marcus Yeoman will become Non-Executive Chairman. Executive Chairman Sarah Cope will become a Non-Executive Director. Non-Executive Director Charles Wood will become Executive Director.
The persons who arranged the release of this information are the Directors of the Company.
*** ENDS ***
Enquiries:
Medcaw Investments Plc [email protected]
Marcus Yeoman
Zeus Capital Ltd 44 203 829 5000
Alexandra Campbell-Harris